ASSET PURCHASE AGREEMENT by and among ARCHIMEDES PHARMA US INC., ARCHIMEDES PHARMA LTD., ARCHIMEDES DEVELOPMENT LTD. and DEPOMED, INC. July 29, 2013Asset Purchase Agreement • November 7th, 2013 • Depomed Inc • Pharmaceutical preparations • New York
THIS ASSET PURCHASE AGREEMENT (this “Agreement”), dated as of July 29, 2013, is made by and among Archimedes Pharma US Inc., a Delaware corporation (“Seller”), Archimedes Pharma Ltd., a corporation registered under the laws of England and Wales (“Parent”), Archimedes Development Ltd., a company registered under the laws of England and Wales (“Archimedes Development”), and Depomed, Inc., a California corporation (“Purchaser”). Each of Seller and Archimedes Development is a wholly owned subsidiary of Parent. Each of Seller, Parent and Archimedes Development is sometimes individually referred to herein as a “Seller Party” and are sometimes collectively referred to herein as the “Seller Parties”. Each Seller Party and Purchaser is sometimes individually referred to herein as a “Party” and are sometimes collectively referred to herein as the “Parties”. Capitalized terms not otherwise defined in the text of this Agreement shall have the meanings set forth in ARTICLE I.
